MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit

Autor: Sanne Løkkegaard, Daniel Elias, Carla L. Alves, Martin V. Bennetzen, Anne-Vibeke Lænkholm, Martin Bak, Morten F. Gjerstorff, Lene E. Johansen, Henriette Vever, Christina Bjerre, Tove Kirkegaard, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Linda S. Lindström, Laura J. Esserman, Anne E. Lykkesfeldt, Jens S. Andersen, Rikke Leth-Larsen, Henrik J. Ditzel

Publikováno v: npj Breast Cancer, Vol 7, Iss 1, Pp 1-15 (2021)

Abstract Resistance to endocrine therapy in estrogen receptor-positive (ER+) breast cancer is a major clinical problem with poorly understood mechanisms. There is an unmet need for prognostic and predictive biomarkers to allow appropriate therapeutic

Externí odkaz: https://doaj.org/article/c7b5ad6a5a674cfcb8ece9f12b5c68d6

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Continued expansion of tick-borne pathogens: Tick-borne encephalitis virus complex and Anaplasma phagocytophilum in Denmark

Autor: Andersen, Nanna Skaarup, Larsen, Sanne Løkkegaard, Olesen, Carsten Riis, Stiasny, Karin, Kolmos, Hans Jørn, Jensen, Per Moestrup, Skarphédinsson, Sigurdur

Publikováno v: In Ticks and Tick-borne Diseases January 2019 10(1):115-123

Contaminated dicloxacillin capsules as the source of an NDM-5/OXA-48-producing Enterobacter hormaechei ST79 outbreak, Denmark and Iceland, 2022 and 2023

Autor: Charlotte Nielsen Agergaard, Lone Jannok Porsbo, Thomas Vognbjerg Sydenham, Sanne Grønvall Kjær Hansen, Kat Steinke, Sanne Løkkegaard Larsen, Kristján Orri Helgason, Frank Hansen, Kasper Thystrup Karstensen, Anna E Henius, Barbara Juliane Holzknecht, Lillian Søes, Kristian Schønning, Mikala Wang, Nina Ank, Anna Margrét Halldórsdóttir, Ólafur Guðlaugsson, Anette M Hammerum, Anne Kjerulf, Brian Kristensen, Henrik Hasman, Ulrik Stenz Justesen

Publikováno v: Agergaard, C N, Porsbo, L J, Sydenham, T V, Hansen, S G K, Steinke, K, Larsen, S L, Helgason, K O, Hansen, F, Karstensen, K T, Henius, A E, Holzknecht, B J, Søes, L, Schønning, K, Wang, M, Ank, N, Halldórsdóttir, A M, Guðlaugsson, Ó, Hammerum, A M, Kjerulf, A, Kristensen, B, Hasman, H & Justesen, U S 2023, ' Contaminated dicloxacillin capsules as the source of an NDM-5/OXA-48-producing Enterobacter hormaechei ST79 outbreak, Denmark and Iceland, 2022 and 2023 ', Eurosurveillance, vol. 28, no. 9 . https://doi.org/10.2807/1560-7917.ES.2023.28.9.2300108
Agergaard, C N, Porsbo, L J, Sydenham, T V, Hansen, S G K, Steinke, K, Larsen, S L, Helgason, K O, Hansen, F, Karstensen, K T, Henius, A E, Holzknecht, B J, Søes, L, Schønning, K, Wang, M, Ank, N, Halldórsdóttir, A M, Guðlaugsson, Ó, Hammerum, A M, Kjerulf, A, Kristensen, B, Hasman, H & Justesen, U S 2023, ' Contaminated dicloxacillin capsules as the source of an NDM-5/OXA-48-producing Enterobacter hormaechei ST79 outbreak, Denmark and Iceland, 2022 and 2023 ', Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, vol. 28, no. 9 . https://doi.org/10.2807/1560-7917.ES.2023.28.9.2300108

From October 2022 through January 2023, nine patients with NDM-5/OXA-48-carbapenemase-producing Enterobacter hormaechei ST79 were detected in Denmark and subsequently one patient in Iceland. There were no nosocomial links between patients, but they h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5150eca4dc139fd736e846be5156baa1
https://vbn.aau.dk/ws/files/525097322/Agergaard_et_al._2023_._Contaminated_dicloxacillin_capsules_as_the_source_of_an_NDM_5_OXA_48_producing_Enterobacter_hormaechei_ST79_outbreak_Denmark_and_Iceland_2022_and_2023.pdf

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit

Autor: Christina Bjerre, Jens S. Andersen, Sanne Løkkegaard, Martin V. Bennetzen, Daniel Elias, Martin Bak, Tommy Fornander, Linda S. Lindström, Tove Kirkegaard, Carla Maria Lourenco Alves, Lene E. Johansen, Anne E. Lykkesfeldt, Anne Vibeke Lænkholm, Rikke Leth-Larsen, Laura J. Esserman, Olle Stål, Henrik J. Ditzel, Morten F. Gjerstorff, Bo Nordenskjöld, Henriette Vever

Publikováno v: NPJ breast cancer, vol 7, iss 1
Løkkegaard, S, Elias, D, Alves, C L, Bennetzen, M V, Lænkholm, A-V, Bak, M, Gjerstorff, M F, Johansen, L E, Vever, H, Bjerre, C, Kirkegaard, T, Nordenskjöld, B, Fornander, T, Stål, O, Lindström, L S, Esserman, L J, Lykkesfeldt, A E, Andersen, J S, Leth-Larsen, R & Ditzel, H J 2021, ' MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit ', npj Breast Cancer, vol. 7, no. 1, pp. 2 . https://doi.org/10.1038/s41523-020-00210-8
npj Breast Cancer, Vol 7, Iss 1, Pp 1-15 (2021)
NPJ Breast Cancer
Løkkegaard, S, Elias, D, Alves, C L, Bennetzen, M V, Lænkholm, A V, Bak, M, Gjerstorff, M F, Johansen, L E, Vever, H, Bjerre, C, Kirkegaard, T, Nordenskjöld, B, Fornander, T, Stål, O, Lindström, L S, Esserman, L J, Lykkesfeldt, A E, Andersen, J S, Leth-Larsen, R & Ditzel, H J 2021, ' MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit ', npj Breast Cancer, vol. 7, 2 . https://doi.org/10.1038/s41523-020-00210-8

Resistance to endocrine therapy in estrogen receptor-positive (ER+) breast cancer is a major clinical problem with poorly understood mechanisms. There is an unmet need for prognostic and predictive biomarkers to allow appropriate therapeutic targetin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b98ea350b249a8cffb0597a2fbcc9544
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-173067